Solid Biosciences Inc.
SLDB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $386 | $407 | $0 |
| Gross Profit | $0 | -$386 | -$407 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $38,861 | $32,415 | $30,914 | $30,770 |
| G&A Expenses | $9,197 | $9,278 | $9,138 | $9,126 |
| SG&A Expenses | $9,197 | $9,278 | $9,138 | $9,126 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$386 | -$407 | $0 |
| Operating Expenses | $48,058 | $41,307 | $39,645 | $39,896 |
| Operating Income | -$48,058 | -$41,693 | -$40,052 | -$39,896 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2,282 | $2,213 | $770 | -$2,701 |
| Pre-Tax Income | -$45,776 | -$39,480 | -$39,282 | -$42,597 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$45,776 | -$39,480 | -$39,282 | -$42,597 |
| % Margin | – | – | – | – |
| EPS | -0.48 | -0.42 | -0.59 | -0.8 |
| % Growth | -14.3% | 28.8% | 26.3% | – |
| EPS Diluted | -0.48 | -0.42 | -0.59 | -0.8 |
| Weighted Avg Shares Out | 94,417 | 94,140 | 66,341 | 53,579 |
| Weighted Avg Shares Out Dil | 94,418 | 94,140 | 66,341 | 53,579 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,586 | $2,966 | $2,300 | $1,925 |
| Interest Expense | $0 | $60 | $68 | $75 |
| Depreciation & Amortization | $376 | $386 | $407 | $488 |
| EBITDA | -$45,400 | -$39,034 | -$38,807 | -$42,034 |
| % Margin | – | – | – | – |